# Cysteamine for Asthma

> **NCT03883984** · PHASE1 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 60 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Cysteamine Bitartrate
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03883984
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-18
- **Primary completion:** 2021-02-10
- **Final completion:** 2021-02-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03883984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03883984, "Cysteamine for Asthma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03883984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*